Kojima: Confirmatory letter.
Kojima: Quarterly report - 62nd period 3rd quarter (03/01/2024-05/31/2024)
Kojima: Announcement of revised financial estimates.
Kojima: Overview of the non-consolidated financial statements for the nine-month period ended May 31, 2024 (based on Japanese accounting standards).
Kojima: Supplementary explanation materials for the third quarter of the August 2024 fiscal year.
Kojima: Third quarter financial results for August 2024 term, based on Japanese standards (non-consolidated).
Kojima: Treasury stock purchase status report (based on Act Section 24-6 (1))
Kojima: Notice regarding treasury stock acquisition results and end of share repurchase through treasury stock off-site repurchase transactions (ToSTNet-3)
Kojima: Notice Concerning Repurchase of Treasury Shares through Off-Site Repurchase Transactions (ToSTNet-3)
Kojima: Quarterly Report - 62nd quarter (2023/12/01 - 2024/02/29)
Kojima: Confirmation
Kojima: Notice Concerning Decisions on Matters Relating to Repurchase of Own Shares
Kojima: Supplementary explanation of financial results for the 2nd quarter of the fiscal year ending 2024/8
Kojima: Overview of unconsolidated financial results for the six months ended 2024/2/29 (based on Japanese accounting standards)
Kojima: Consolidated Financial Results for the 2nd Quarter Ending August 2024 [Japanese GAAP] (Unconsolidated)
Kojima: Kojima certified as an excellent health management corporation 2024 (white 500)
Kojima: Announcement of publication of the “Integrated Report 2023”
Kojima: Integrated Report 2023
Kojima: Confirmation letter
Kojima: Quarterly Report - 62nd Quarter (2023/09/01 to 2023/11/30)
No Data